Presence of complement-dependent cytotoxic activity against clonally-derived rat islet tumour cells in sera from Type 1 (insulin-dependent) diabetic patients and control subjects-Reference-Cited by-同舟云学术

Presence of complement-dependent cytotoxic activity against clonally-derived rat islet tumour cells in sera from Type 1 (insulin-dependent) diabetic patients and control subjects

Published:1986-09 Issue:9 Volume:29 Page:616-622
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Cavender D. E.,Virji M. A.,Holze-Joost S.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00869259.pdf

Reference27 articles.

1. Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619?633

2. Bottazzo GF, Florin-Chistensen F, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with polyendocrine deficiencies. Lancet 2: 1279?1283

3. MacCuish AC, Barnes EW, Irvine WJ, Duncan LJ (1974) Antibodies to pancreatic islet-cells in insulin-dependent diabetic with co-existent autoimmune disease. Lancet 2: 1529?1531

4. Maclaren NK, Huang S, Fogh J (1975) Antibody to cultured human insulinoma cells in insulin-dependent diabetics. Lancet 1: 997?999

5. Neuy J, Andersen 00, Bendixen G, Egeberg J, Poulsen JE (1971) Antipancreatic cellular hypersensitivity in diabetes mellitus. Diabetes 20: 693?697

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement-Mediated Cytotoxic Effects of Islet Cell Surface Antibodies in Non-Diabetic Subjects with Antecedent Mumps Infection and Diabetic Risk;Experimental and Clinical Endocrinology & Diabetes;2009-07-16

2. Evidence for complement-dependent and -independent inhibition of insulin secretion from clonal beta-cells incubated in the presence of sera of newly diagnosed IDDM patients;Journal of Endocrinology;2000-02-01

3. Evidence for enhanced rates of complement activation in serum from patients with newly diagnosed insulin-dependent diabetes mellitus exposed to rat islet cells and complement-dependent induction of islet cell apoptosis;Journal of Endocrinology;1999-07-01

4. Complement-Fixing Islet Cell Antibodies in Type-1 Diabetes Can Trigger the Assembly of the Terminal Complement Complex on Human Islet Cells and Are Potentially Cytotoxic;Clinical Immunology and Immunopathology;1996-06

5. Lack of specificity of islet cell surface antibodies (ICSA) in IDDM;Diabetes Research and Clinical Practice;1992-07